Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/20/15 → 12/18/17 |
Funding
- Covance Inc. (Prot #BAY-1187982-16897 // Prot #BAY-1187982-16897)
- Bayer HealthCare Pharmaceuticals, Inc. (Prot #BAY-1187982-16897 // Prot #BAY-1187982-16897)
Prot #BAY-1187982-16897: An Open-Label, Phase I, Dose-Escalation Trial to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Pharmacodynamics of the Anti-FGFR2 Antibody Drug Conjugate BAY 1187982 in Subjects with Advanced Sol
- Kalyan, Aparna (PD/PI)
Project: Research project